Autonomix Medical, Inc.
AMIX
$1.03
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.83M | 1.60M | 1.60M | 1.66M | 1.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 100.00K | 100.00K | -- | -- |
| Total Operating Expenses | 3.42M | 3.25M | 2.75M | 2.84M | 2.75M |
| Operating Income | -3.42M | -3.25M | -2.75M | -2.84M | -2.75M |
| Income Before Tax | -3.34M | -3.19M | -2.71M | -2.81M | -2.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.34M | -3.19M | -2.71M | -2.81M | -2.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.34M | -3.19M | -2.71M | -2.81M | -2.70M |
| EBIT | -3.42M | -3.25M | -2.75M | -2.84M | -2.75M |
| EBITDA | -3.42M | -3.20M | -2.70M | -2.79M | -2.71M |
| EPS Basic | -1.07 | -1.16 | -1.46 | -2.47 | -2.20 |
| Normalized Basic EPS | -0.67 | -0.72 | -0.92 | -1.54 | -1.38 |
| EPS Diluted | -1.07 | -1.16 | -1.46 | -2.47 | -2.20 |
| Normalized Diluted EPS | -0.67 | -0.72 | -0.92 | -1.54 | -1.38 |
| Average Basic Shares Outstanding | 3.11M | 2.75M | 1.85M | 1.14M | 1.23M |
| Average Diluted Shares Outstanding | 3.11M | 2.75M | 1.85M | 1.14M | 1.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |